Pregabalin 75 Mg

Pregabalin capsule or oral liquid may be taken with or without food. Take the extended-release tablet after an evening meal. Swallow it whole. Do not crush, break, or chew it.

Store the medicine at room temperature, away from heat, moisture, and direct light.

Side effects may include constipation, dry mouth, diplopia, weight gain, edema , ataxia, and difficulty with concentration or attention, dizziness.

Avoid use of this drug during pregnancy. Evidence has demonstrated fetal abnormalities or risks when used during pregnancy and breastfeeding.

The use of alcohol or other medicines that affect the CNS with pregabalin may worsen the side effects of this medicine, such as dizziness, poor concentration, drowsiness, unusual dreams, and trouble with sleeping This medicine may cause respiratory depression, a serious breathing problem that can be life-threatening, when used together with narcotic pain medicines. Check with your doctor right away Pregabalin may cause blurred vision, double vision, clumsiness, unsteadiness, dizziness, drowsiness, or trouble with thinking. Do not drive or do anything else that could be dangerous until you know how this medicine affects you. If these side effects are especially bothersome, check with your doctor. Do not suddenly stop taking pregabalin without checking first with your doctor. patient to avoid drinking alcohol Extended-release tablets: If a dose is missed with the evening meal, instruct patient to take before bedtime after a snack or the following morning after a meal.

Product Information: LYRICA(R) CR oral extended-release tablets, pregabalin oral extended-release tablets. Viatris Specialty LLC (per FDA), Morgantown, WV, 2023. Product Information: LYRICA(R) oral capsules, pregabalin oral capsules. Pfizer,Inc, New York, NY, 2007. Feltner DE, Crockatt JG, Dubovsky SJ, et al: A randomized, double-blind, placebo-controlled, fixed-dose, multicenter study of pregabalin in patients with generalized anxiety disorder. J Clin Psychopharmacol 2003; 23(3):240-249."

Pregabalin is an anticonvulsant and analgesic medication that binds to calcium channels in the central nervous system. By binding to the α2-δ subunit of voltage-gated calcium channels, Pregabalin modulates the release of neurotransmitters, including glutamate, norepinephrine, and substance P, which are involved in pain signaling. This mechanism of action is believed to contribute to Pregabalin's efficacy in managing neuropathic pain, epilepsy, and generalized anxiety disorder.

Neuropathic Pain Agent